CSF2 and autoimmune disease: High levels of AAbs that neutralize GM-CSF signaling cause autoimmune pulmonary alveolar proteinosis (aPAP), an ultrarare autoimmune disease characterized by accumulation of excess surfactant in the alveoli, leading to pulmonary insufficiency.